Factors that influence whether patients with cancer involve families in decision-making identified
the ONA take:
According to a new study published in the journal Cancer, researchers from Harvard Medical School in Boston, Massachusetts, have identified certain factors that influence whether patients with cancer involve their family members in treatment decisions.
For the study, researchers surveyed 5,284 patients with newly diagnosed colon or lung cancer, and asked them how they involved their family members in treatment decisions.
Results showed that only 1.5% of participants reported family-controlled decisions, while 49.4% reported equally sharing decisions with family members, 22.1% report some input from family members, and 28.5% reported little to no input from family members.
The researchers also found that non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to equally share decisions with their family members compared with other patients.
Patients who were female, insured, married, and older were also more often to equally share decisions with their family members versus other patients, while veterans were least likely to involve family members in treatment decisions.
The authors hope that the findings will help physicians to better assess their patients' preferences for involving their families in treatment decisions.
Certain factors influence whether patients with cancer involve their family members in treatment decisions.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|